Statistical analysis reveals reduced false discoveries in mass spectrometry imaging and single-cell data, suggesting improved biological insights.
Motivation Mass spectrometry imaging (MSI) and single-cell RNA sequencing (scRNA-seq) offer high-resolution views into tissue and cellular heterogeneity. However, conventional statistical analyses often treat sub-measurements (pixels or cells) as independent, ignoring their nested origin from individual samples. This assumption inflates the effective sample size, increases false discoveries, and undermines biological interpretation. Pixel- or cell-level averaging avoids this but sacrifices spatial or cellular resolution. Results We evaluated block-SAM on both simulated and real-world datasets. In DESI-MSI data from kidney, lung, and ovarian tumors, block-SAM consistently identified fewer—but more reliable—differential features compared to traditional-SAM. For example, in the kidney dataset, traditional-SAM identified 569 features between tumor and normal tissue, while block-SAM identified 186—all overlapping but excluding 383 likely false positives. Applied to a metastatic RCC scRNA-seq dataset comparing immune checkpoint blockade (ICB)-treated vs. untreated patients, traditional-SAM identified over 19,000 differentially expressed genes in malignant cells; block-SAM reduced this to 19. These results demonstrate block-SAM’s ability to reduce false discoveries while retaining biologically meaningful signals across diverse high-dimensional datasets. Availability All code and data associated with this study are deposited on Zenodo (https://doi.org/10.5281/zenodo.18273497). The samr package is freely available on the Comprehensive R Archive Network (CRAN). Supplementary information Supplementary data are available at Bioinformatics online.
No takes yet. Share an insight, caveat, or question.
Liebenberg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: